Astellas Pharma Inc. (ALPMF)
OTCMKTS
· Delayed Price · Currency is USD
9.70
0.00 (0.00%)
May 14, 2025, 4:00 PM EDT
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| Pharmaceutical | 1,603.67B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Growth | 5.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| United States | 663.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 1.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Established Markets | 415.57B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Established Markets Growth | 15.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 270.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | 2.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 159.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | 9.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Greater China | 88.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Greater China Growth | 10.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 7.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -64.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|